|
Volume 272, Number 41,
Issue of October 10, 1997
pp. 25576-25582
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Apolipoprotein L, a New Human High Density Lipoprotein
Apolipoprotein Expressed by the Pancreas
IDENTIFICATION, CLONING, CHARACTERIZATION, AND PLASMA
DISTRIBUTION OF APOLIPOPROTEIN L
(Received for publication, April 21, 1997, and in revised form, July 21, 1997)
Philippe N.
Duchateau
,
Clive R.
Pullinger
,
Roberto E.
Orellana
,
Steven T.
Kunitake
,
Josefina
Naya-Vigne
,
Patricia M.
O'Connor
,
Mary J.
Malloy
and
John P.
Kane
From the Cardiovascular Research Institute, University of
California, San Francisco, California 94143-0130
In this study, we have identified and
characterized a new protein present in human high density lipoprotein
that we have designated apolipoprotein L. Using a combination of
liquid-phase isoelectrophoresis and high resolution two-dimensional gel
electrophoresis, apolipoprotein L was identified and partially
sequenced from immunoisolated high density lipoprotein (Lp(A-I)).
Expression was only detected in the pancreas. The cDNA sequence
encoding the full-length protein was cloned using reverse
transcription-polymerase chain reaction. The deduced amino acid
sequence contains 383 residues, including a typical signal peptide of
12 amino acids. No significant homology was found with known
sequences. The plasma protein is a single chain polypeptide
with an apparent molecular mass of 42 kDa. Antibodies raised against
this protein detected a truncated form with a molecular mass of 39 kDa.
Both forms were predominantly associated with immunoaffinity-isolated
apoA-I-containing lipoproteins and detected mainly in the density range
1.123 < d < 1.21 g/ml. Free apoL was not
detected in plasma. Anti-apoL immunoaffinity chromatography was used to
purify apoL-containing lipoproteins (Lp(L)) directly from plasma.
Nondenaturing gel electrophoresis of Lp(L) showed two major molecular
species with apparent diameters of 12.2-17 and 10.4-12.2 nm.
Moreover, Lp(L) exhibited both pre- and electromobility. Apolipoproteins A-I, A-II, A-IV, and C-III were also detected in the
apoL-containing lipoprotein particles.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. E. Smith and H. S. Malik
The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions
Genome Res.,
May 1, 2009;
19(5):
850 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Molina-Portela, M. Samanovic, and J. Raper
Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model
J. Exp. Med.,
August 4, 2008;
205(8):
1721 - 1728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wan, S. Zhaorigetu, Z. Liu, R. Kaini, Z. Jiang, and C.-a. A. Hu
Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell Death
J. Biol. Chem.,
August 1, 2008;
283(31):
21540 - 21549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vanhollebeke, G. De Muylder, M. J. Nielsen, A. Pays, P. Tebabi, M. Dieu, M. Raes, S. K. Moestrup, and E. Pays
A Haptoglobin-Hemoglobin Receptor Conveys Innate Immunity to Trypanosoma brucei in Humans
Science,
May 2, 2008;
320(5876):
677 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-i. Kawada, H. Kimura, Y. Kamachi, K. Nishikawa, M. Taniguchi, K. Nagaoka, H. Kurahashi, S. Kojima, and T. Morishima
Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza
J. Gen. Virol.,
June 1, 2006;
87(6):
1677 - 1683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Oli, L. F. Cotlin, A. M. Shiflett, and S. L. Hajduk
Serum Resistance-Associated Protein Blocks Lysosomal Targeting of Trypanosome Lytic Factor in Trypanosoma brucei
Eukaryot. Cell,
January 1, 2006;
5(1):
132 - 139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Shiflett, J. R. Bishop, A. Pahwa, and S. L. Hajduk
Human High Density Lipoproteins Are Platforms for the Assembly of Multi-component Innate Immune Complexes
J. Biol. Chem.,
September 23, 2005;
280(38):
32578 - 32585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Perez-Morga, B. Vanhollebeke, F. Paturiaux-Hanocq, D. P. Nolan, L. Lins, F. Homble, L. Vanhamme, P. Tebabi, A. Pays, P. Poelvoorde, et al.
Apolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes
Science,
July 15, 2005;
309(5733):
469 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. E. Albert, P. N. Duchateau, S. S. Deeb, C. R. Pullinger, M. H. Cho, D. C. Heilbron, M. J. Malloy, J. P. Kane, and B. G. Brown
Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL
J. Lipid Res.,
March 1, 2005;
46(3):
469 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Liu, H. Lu, Z. Jiang, A. Pastuszyn, and C.-a. A. Hu
Apolipoprotein L6, a Novel Proapoptotic Bcl-2 Homology 3-Only Protein, Induces Mitochondria-Mediated Apoptosis in Cancer Cells
Mol. Cancer Res.,
January 1, 2005;
3(1):
21 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Regard, S. Scheek, T. Borbiev, A. A. Lanahan, A. Schneider, A.-M. Demetriades, H. Hiemisch, C. A. Barnes, A. D. Verin, and P. F. Worley
Verge: A Novel Vascular Early Response Gene
J. Neurosci.,
April 21, 2004;
24(16):
4092 - 4103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Mimmack, M. Ryan, H. Baba, J. Navarro-Ruiz, S. Iritani, R. L. M. Faull, P. J. McKenna, P. B. Jones, H. Arai, M. Starkey, et al.
Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22
PNAS,
April 2, 2002;
99(7):
4680 - 4685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. N. Duchateau, C. R. Pullinger, M. H. Cho, C. Eng, and J. P. Kane
Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene
J. Lipid Res.,
April 1, 2001;
42(4):
620 - 630.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. CANDIANO, L. MUSANTE, M. CARRARO, L. FACCINI, L. CAMPANACCI, C. ZENNARO, M. ARTERO, F. GINEVRI, F. PERFUMO, R. GUSMANO, et al.
Apolipoproteins Prevent Glomerular Albumin Permeability Induced In Vitro by Serum from Patients with Focal Segmental Glomerulosclerosis
J. Am. Soc. Nephrol.,
January 1, 2001;
12(1):
143 - 150.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. N. Duchateau, I. Movsesyan, S. Yamashita, N. Sakai, K.-I. Hirano, S. A. Schoenhaus, P. M. O'Connor-Kearns, S. J. Spencer, R. B. Jaffe, R. F. Redberg, et al.
Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects
J. Lipid Res.,
August 1, 2000;
41(8):
1231 - 1236.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Xu and B. Dahlback
A Novel Human Apolipoprotein (apoM)
J. Biol. Chem.,
October 29, 1999;
274(44):
31286 - 31290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J.G. Horrevoets, R. D. Fontijn, A. J. van Zonneveld, C. J.M. de Vries, J. W. ten Cate, and H. Pannekoek
Vascular Endothelial Genes That Are Responsive to Tumor Necrosis Factor-{alpha} In Vitro Are Expressed in Atherosclerotic Lesions, Including Inhibitor of Apoptosis Protein-1, Stannin, and Two Novel Genes
Blood,
May 15, 1999;
93(10):
3418 - 3431.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|